Cargando…

Alzheimer’s Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer’s Disease and Type 2 Diabetes

Globally, the incidence of type 2 diabetes mellitus (T2DM) and Alzheimer’s disease (AD) epidemics is increasing rapidly and has huge financial and emotional costs. The purpose of the current review article is to discuss the shared pathophysiological connections between AD and T2DM. Research findings...

Descripción completa

Detalles Bibliográficos
Autores principales:	Michailidis, Michalis, Moraitou, Despina, Tata, Despina A., Kalinderi, Kallirhoe, Papamitsou, Theodora, Papaliagkas, Vasileios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910482/ https://www.ncbi.nlm.nih.gov/pubmed/35269827 http://dx.doi.org/10.3390/ijms23052687

Ejemplares similares

Antidiabetic Drugs in the Treatment of Alzheimer’s Disease
por: Michailidis, Michalis, et al.
Publicado: (2022)

CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease
por: Papaliagkas, Vasileios, et al.
Publicado: (2023)

Type 2 diabetes mellitus in the pathophysiology of Alzheimer's disease
por: de Nazareth, Aparecida Marcelino
Publicado: (2017)

Episodic Memory in Amnestic Mild Cognitive Impairment (aMCI) and Alzheimer’s Disease Dementia (ADD): Using the “Doors and People” Tool to Differentiate between Early aMCI—Late aMCI—Mild ADD Diagnostic Groups
por: Chatzikostopoulos, Athanasios, et al.
Publicado: (2022)

Trajectories of Cognitive Impairment in Adults Bearing Vascular Risk Factors, with or without Diagnosis of Mild Cognitive Impairment: Findings from a Longitudinal Study Assessing Executive Functions, Memory, and Social Cognition
por: Tsentidou, Glykeria, et al.
Publicado: (2022)

Correlates of Functional Impairment in Patients with the Behavioral Variant of Frontotemporal Dementia: A PRISMA-Compliant Systematic Review
por: Chatzidimitriou, Electra, et al.
Publicado: (2023)

Alzheimer’s disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics links
por: Rojas, Milagros, et al.
Publicado: (2021)

Resilience in Mild Cognitive Impairment (MCI): Examining the Level and the Associations of Resilience with Subjective Wellbeing and Negative Affect in Early and Late-Stage MCI
por: Tsormpatzoudi, Styliani Olympia, et al.
Publicado: (2023)

Inefficient understanding of non-factive mental verbs with social aspect in adults: comparison to cognitive factive verb processing
por: Nazlidou, Elena-Ioanna, et al.
Publicado: (2018)

R4Alz-Revised: A Tool Able to Strongly Discriminate ‘Subjective Cognitive Decline’ from Healthy Cognition and ‘Minor Neurocognitive Disorder’
por: Poptsi, Eleni, et al.
Publicado: (2023)

Amylin Receptor: A Common Pathophysiological Target in Alzheimer’s Disease and Diabetes Mellitus
por: Fu, Wen, et al.
Publicado: (2013)

A Pathophysiological Intersection of Diabetes and Alzheimer’s Disease
por: Čater, Maša, et al.
Publicado: (2022)

Inhibitory Control, Task/Rule Switching, and Cognitive Planning in Vascular Dementia: Are There Any Differences From Vascular Aging?
por: Pantsiou, Krystallia, et al.
Publicado: (2018)

The Relationships between Character Strengths and Subjective Wellbeing: Evidence from Greece under Lockdown during COVID-19 Pandemic
por: Vasileiou, Dimitra, et al.
Publicado: (2021)

Pathophysiological Association Between Diabetes Mellitus and Alzheimer's Disease
por: Agrawal, Manasi, et al.
Publicado: (2022)

The Association between the Binding Processes of Working Memory and Vascular Risk Profile in Adults
por: Bika, Eirini, et al.
Publicado: (2021)

Type 2 Diabetes Mellitus and Alzheimer’s Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets
por: Hamzé, Rim, et al.
Publicado: (2022)

Metacognitive Strategy Training Improves Decision-Making Abilities in Amnestic Mild Cognitive Impairment
por: Pikouli, Foteini Aikaterini, et al.
Publicado: (2023)

Testosterone-induced hypertrophy, fibrosis and apoptosis of cardiac cells – an ultrastructural and immunohistochemical study
por: Papamitsou, Theodora, et al.
Publicado: (2011)

A Common Pathogenic Mechanism Linking Type-2 Diabetes and Alzheimer's Disease: Evidence from Animal Models
por: Park, Sun Ah
Publicado: (2011)

Cross-disease analysis of Alzheimer’s disease and type-2 Diabetes highlights the role of autophagy in the pathophysiology of two highly comorbid diseases
por: Caberlotto, Laura, et al.
Publicado: (2019)

Mechanism of quercetin therapeutic targets for Alzheimer disease and type 2 diabetes mellitus
por: Zu, Guoxiu, et al.
Publicado: (2021)

Toxic Environmental Factors and their Association with the Development of Dementia: a Mini Review on Heavy Metals and Ambient Particulate Matter
por: Antoniadou, Fevronia, et al.
Publicado: (2020)

Stress, Anxiety, and Depression Levels among University Students: Three Years from the Beginning of the Pandemic
por: Kavvadas, Dimitrios, et al.
Publicado: (2023)

Antioxidant Potential of Spray- and Freeze-Dried Extract from Oregano Processing Wastes, Using an Optimized Ultrasound-Assisted Method
por: Vareltzis, Patroklos, et al.
Publicado: (2023)

Association of microRNA Polymorphisms with Toxicities Induced by Methotrexate in Children with Acute Lymphoblastic Leukemia
por: Karpa, Vasiliki, et al.
Publicado: (2023)

Common mechanisms involved in Alzheimer's disease and type 2 diabetes: a key role of chronic bacterial infection and inflammation
por: Miklossy, Judith, et al.
Publicado: (2016)

Insulin in the Brain: Its Pathophysiological Implications for States Related with Central Insulin Resistance, Type 2 Diabetes and Alzheimer’s Disease
por: Blázquez, Enrique, et al.
Publicado: (2014)

Inflammation and the pathophysiology of Alzheimer's disease
por: Greer, M. Murphy Jr.
Publicado: (2000)

Histologic evaluation of femoral nerve demyelinating and axonal neuropathy in Wistar rats due to alendronate intake: a randomised study
por: Theodora, Papamitsou, et al.
Publicado: (2020)

Alzheimer's disease and Type 2 diabetes mellitus: the cholinesterase connection?
por: Allam, Appa Rao, et al.
Publicado: (2006)

Is There Inflammatory Synergy in Type II Diabetes Mellitus and Alzheimer's Disease?
por: Lue, Lih-Fen, et al.
Publicado: (2012)

Type 3 Diabetes and Its Role Implications in Alzheimer’s Disease
por: Nguyen, Thuy Trang, et al.
Publicado: (2020)

Can Alzheimer's Disease Be Secondary to Type-2 Diabetes Mellitus?
por: Jangra, Vani, et al.
Publicado: (2022)

Exploring the common pathogenesis of Alzheimer’s disease and type 2 diabetes mellitus via microarray data analysis
por: Ye, Xian-wen, et al.
Publicado: (2023)

Exploring the Role of Hsp60 in Alzheimer’s Disease and Type 2 Diabetes: Suggestion for Common Drug Targeting
por: Zimbone, Stefania, et al.
Publicado: (2023)

Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment
por: Li, Xiaohua, et al.
Publicado: (2015)

Effects and Underlying Mechanisms of Bioactive Compounds on Type 2 Diabetes Mellitus and Alzheimer's Disease
por: Li, Rongzi, et al.
Publicado: (2019)

Emerging Pathophysiological Mechanisms Linking Diabetes Mellitus and Alzheimer’s Disease: An Old Wine in a New Bottle
por: Patel, Vishvas N., et al.
Publicado: (2022)

Regional mitochondrial DNA and cell-type changes in post-mortem brains of non-diabetic Alzheimer’s disease are not present in diabetic Alzheimer’s disease
por: Thubron, Elisabeth B., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tcmbq0fmi2andk4b4rfve7bm2c